We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $95.5B
1-Year Est. Return 28.4%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
Cap. Flow
-$2.07B
Cap. Flow %
-2.5%
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$433M
2
LOW icon
Lowe's Companies
LOW
+$277M
3
ORCL icon
Oracle
ORCL
+$226M
4
PGR icon
Progressive
PGR
+$220M
5
LVS icon
Las Vegas Sands
LVS
+$167M

Sector Composition

Rank Sector Weight
1 Financials 19.96%
2 Healthcare 15.3%
3 Industrials 15.12%
4 Technology 14.91%
5 Consumer Discretionary 11.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LEA icon
126
Lear
LEA
$7.19B
$228M 0.27%
1,244,209
-783,061
-39% -$137M
MAS icon
127
Masco
MAS
$16B
$227M 0.27%
3,238,650
-79,525
-2% -$5.14M
LDOS icon
128
Leidos
LDOS
$14.1B
$227M 0.27%
2,555,773
-48,727
-2% -$4.56M
MDT icon
129
Medtronic
MDT
$107B
$227M 0.27%
2,194,216
-387,139
-15% -$44.8M
EIX icon
130
Edison International
EIX
$30.7B
$225M 0.27%
3,294,028
-26,410
-0.8% -$1.67M
CCK icon
131
Crown Holdings
CCK
$12.8B
$224M 0.27%
2,023,336
+397,454
+24% +$42.2M
TGNA
132
DELISTED
TEGNA Inc
TGNA
$223M 0.27%
12,018,001
+185,681
+2% +$3.72M
HCA icon
133
HCA Healthcare
HCA
$84.8B
$217M 0.26%
846,504
-9,109
-1% -$2.23M
TMUS icon
134
T-Mobile US
TMUS
$193B
$216M 0.26%
1,863,494
+157,350
+9% +$18.5M
SLM icon
135
SLM Corp
SLM
$4.57B
$215M 0.26%
10,923,597
-80,179
-0.7% -$1.47M
LHX icon
136
L3Harris
LHX
$55.9B
$215M 0.26%
1,008,067
-13,948
-1% -$3.09M
ESS icon
137
Essex Property Trust
ESS
$18.9B
$211M 0.25%
599,881
-4,759
-0.8% -$1.62M
EXPD icon
138
Expeditors International
EXPD
$22.9B
$210M 0.25%
1,563,930
-37,202
-2% -$4.66M
FLEX icon
139
Flex
FLEX
$43.4B
$209M 0.25%
15,123,490
-380,691
-2% -$5.15M
CHTR icon
140
Charter Communications
CHTR
$14.7B
$206M 0.25%
316,508
-132,145
-29% -$90M
NSC icon
141
Norfolk Southern
NSC
$78.8B
$206M 0.25%
692,013
+100,208
+17% +$28M
WDC icon
142
Western Digital
WDC
$179B
$201M 0.24%
4,071,363
-656,761
-14% -$28.5M
EVTC icon
143
Evertec
EVTC
$1.83B
$200M 0.24%
4,011,330
-586,443
-13% -$27.1M
CNXC icon
144
Concentrix
CNXC
$1.36B
$200M 0.24%
1,121,433
-66,492
-6% -$11.9M
LRCX icon
145
Lam Research
LRCX
$382B
$200M 0.24%
2,779,800
-1,710,320
-38% -$107M
REZI icon
146
Resideo Technologies
REZI
$5.23B
$194M 0.23%
7,469,125
+3,567,958
+91% +$92.5M
TRV icon
147
Travelers Companies
TRV
$80.8B
$194M 0.23%
1,238,416
-35,939
-3% -$5.62M
WMS icon
148
Advanced Drainage Systems
WMS
$10.9B
$193M 0.23%
1,415,975
+599,778
+73% +$73.7M
VVV icon
149
Valvoline
VVV
$4.97B
$191M 0.23%
5,136,328
-490,554
-9% -$17.1M
VLO icon
150
Valero Energy
VLO
$89.8B
$188M 0.23%
2,507,229
+734,466
+41% +$54.7M

Similar funds

Boston Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.

  • Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
  • Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
  • Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
  • Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
  • Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
  • Boston Partners opened 59 new positions and closed 45 in Q4 2021.
  • Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.

Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.